Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BayStreetWildon Dec 23, 2021 10:41am
149 Views
Post# 34257857

RE:Bay Street

RE:Bay Street

First of all, there is no old narrative or new narrative. There is only the narrative of why I am down money. 

Second, I can't fire or hire anyone and since the board reserves that right I have to live with the fact that our ceo is here to stay. I can sell at a loss which I find to be unnecessary because the market cap is so low it basically reads that the company has no chance for success. I don't believe that to be the case. The clinical side has managed to get through quite a bit with the FDA to get where they are and I see them continuing to do that.

My request is pretty simple and my complaints are pretty logical.

Do what you are going to say you are going to do. In the time you say you're going to do it.  For the price you said that we will pay. Please don't insult my intelligence by stating things which are obviously untrue (ie sept presentation where it states 60% enrolment by dec 2021)

I don't think that's too much to ask. Do you? If they don't, they'll continue to disappoint shareholders who will get tired for waiting and sell, and that will open the door to manipulation downwards for short sellers and people/institutions who can really move the stock but want in on private placements and refuse to put a penny into the market knowing one is coming any minute. Whether their motives be to cover their short position or simply get a free warrant.

Lastly, management has acknowledged shortcomings and for the first time in history, that I can recall, adressed some hard to deal with issues. Because of that, I'm willing to sit it out one more time, if for any reason other than to support the clinical side and their advances and to not take a giant loss. 


 


Domino55 wrote: You seem to be the champion of the new narrative: They came clean in the most recent presentation and all is good. All is good moving forward.

maybe you are correct but was in necessary to allow the SP to drop to all time lows amongst such clinical advancements? Are we to believe that 2% of NPV and historical lows is the best they can muster? Was it really necessary to suffer through another tax loss season at this late stage of development.

I'll continue to follow you, if for no other reason than the bashers are always right with Spectral. Always have been. It's a funny tale that way.

 

<< Previous
Bullboard Posts
Next >>